4//SEC Filing
Hodges Philip 4
Accession 0001012975-17-000759
CIK 0001326190other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 8:04 PM ET
Size
9.1 KB
Accession
0001012975-17-000759
Insider Transaction Report
Form 4
Hodges Philip
Director
Transactions
- Award
Stock Options (option to buy)
2017-10-13+20,000→ 20,000 totalExercise: $2.50From: 2018-04-30Exp: 2027-10-13→ Common Stock, par value $0.0001 (20,000 underlying) - Other
Common Stock, par value $0.0001
2017-10-17−1,278,471→ 0 total(indirect: See Footnote)
Transactions
- Award
Stock Options (option to buy)
2017-10-13+20,000→ 20,000 totalExercise: $2.50From: 2018-04-30Exp: 2027-10-13→ Common Stock, par value $0.0001 (20,000 underlying) - Other
Common Stock, par value $0.0001
2017-10-17−1,278,471→ 0 total(indirect: See Footnote)
Footnotes (3)
- [F1]Redmont VAXN Capital Holdings, LLC, a Delaware limited liability company ("Redmont VAXN") distributed to its members, pro rata and without consideration, 1,278,471 shares of the Issuer's common stock.
- [F2]Consists of shares of Common Stock held by Redmont VAXN. Philip Hodges has sole voting and dispositive control with respect to all securities held by Redmont VAXN. Philip Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
- [F3]Held by Philip Hodges.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001705562
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 8:04 PM ET
- Size
- 9.1 KB